Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meihua International Medical Technologies CoMHUAF 59 Return-on-Tangible-Asset is 3.67% as of Dec. 2025, which is 48% below its 10-year median of 7.02. GuruFocus rates MHUAF with a GF Score™ of 59/100 and a GF Value™ of $26.50 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Meihua International Medical Technologies Co ranks better than 61.24% on this metric.
MHUAF's Return-on-Tangible-Asset is ranked better than 61.24% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.665
vs MHUAF: 3.49
Meihua International Medical Technologies Co (OTCPK:MHUAF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Meihua International Medical Technologies Co Return-on-Tangible-Asset Related Terms
Meihua International Medical Technologies Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co Return-on-Tangible-Asset Chart
Meihua International Medical Technologies Co Annual Data
MHUAF vs CUPR, LUCY, NXGL: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meihua International Medical Technologies Co Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Meihua International Medical Technologies Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Meihua International Medical Technologies Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 3.67% mean?
Meihua International Medical Technologies Co (MHUAF) has a Return-on-Tangible-Asset of 3.67% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Meihua International Medical Technologies Co and its competitors. This is 48% below median its historical median of 7.02. Over the past decade, Meihua International Medical Technologies Co's Return-on-Tangible-Asset has ranged from 3.46 to 27.15. According to the industry distribution chart, Meihua International Medical Technologies Co ranks #331 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 38.8%.
Is Meihua International Medical Technologies Co's Return-on-Tangible-Asset too high?
Meihua International Medical Technologies Co's current Return-on-Tangible-Asset of 3.67% is 48% below median its 10-year median of 7.02. Over the past 10 years, this metric has ranged from a low of 3.46 to a high of 27.15. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.67. Meihua International Medical Technologies Co's value of 3.67% is 451.9% above this industry median. Based on the distribution chart, Meihua International Medical Technologies Co ranks #331 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Meihua International Medical Technologies Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meihua International Medical Technologies Co's Return-on-Tangible-Asset compare to CUPR and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Meihua International Medical Technologies Co ranks #331 out of 854 companies for Return-on-Tangible-Asset. This puts Meihua International Medical Technologies Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.67. Meihua International Medical Technologies Co's value of 3.67% is 451.9% above this benchmark. Historically, Meihua International Medical Technologies Co's own Return-on-Tangible-Asset has ranged from 3.46 to 27.15 over the past decade. While the company's 10-year median is 7.02 vs. the industry median of 0.67, Meihua International Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.67, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meihua International Medical Technologies Co's current Return-on-Tangible-Asset of 3.67% is 451.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Meihua International Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meihua International Medical Technologies Co's current Return-on-Tangible-Asset is 3.67%, which is 48% below median its own 10-year median of 7.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihua International Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co (MHUAF) is currently considered Possible Value Trap. The stock's GF Value™ is $26.50, compared to a current price of $8.77 — trading 66.9% below its estimated fair value. The current Return-on-Tangible-Asset is 3.67%, which is 48% below median its 10-year median of 7.02 and 451.9% above the Medical Devices & Instruments industry median of 0.67. Meihua International Medical Technologies Co's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Meihua International Medical Technologies Co (MHUAF), the current Return-on-Tangible-Asset is 3.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Meihua International Medical Technologies Co (MHUAF) Overvalued in 2026?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co stock appears to be undervalued.
The current stock price of $8.77 is trading 66.9% below its estimated GF Value™ of $26.50.
GuruFocus considers Meihua International Medical Technologies Co to be Possible Value Trap.
Key valuation signals for MHUAF:
Return-on-Tangible-Asset: 3.67% (48% below median its 10-year median of 7.02)
GF Value™: $26.50 vs. price of $8.77 (66.9% below fair value)
Industry Position: 451.9% above the Medical Devices & Instruments median (#331 of 854)
No single metric tells the full story. See the MHUAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
59GF Score
Get the complete analysis for MHUAF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHUAF has been successfully added to your 
